Novaicos is the acronym of Novara and ICOS the molecule studied within the company. Novaicos Srls was founded in May 2016 as and Academic Spin-off company by a group of researcher from University of Novara and University of Torino. NOVAICOS is an innovative Start Up.
Novaicos is a new biotech company focused on innovative approach for the therapy of bone-loss related diseases. Novaicos develops its patented active substance, the only immune-derived